NCT05050162: A trial that was reported late by NRG Oncology
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT05050162 |
|---|---|
| Title | Randomized Phase II/III Trial of Radiation With Cisplatin at 100 mg/m2 Every Three Weeks Versus Radiation With Weekly Cisplatin at 40 mg/m2 for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 1, 2022 |
| Completion date | Feb. 9, 2026 |
| Required reporting date | Feb. 9, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 12, 2025 |
| Days late | None |